Go to Investment Week homepage
  • Site search
  • Job search
  • Subscribe
  • Newsletter
  • Mobile
  • RSS
  • Home
  • News
  • Opinion
  • Fund Manager Views
  • Interviews
  • Sector Analysis
  • Features
  • Events
  • Audio/Video
  • Jobs
  • Research Centre
  • Share Centre
  • About us
  • Contact us
  • Advertise
  • UK
  • Global
  • Fixed Income
  • Managed
  • Specialist
  • Markets
  • Goslings Grouse
  • Contrarian Investor
  • Leader
  • The Alchemist
  • The Big Interview
  • Fund Manager Focus
  • Funds to watch (RADAR)
  • Practical
  • Technical
  • The Big Question
  • Conjecture
Where am I? breadcrumbs arrow image Home breadcrumbs arrow image  Feature breadcrumbs arrow image Investment breadcrumbs arrow image UK

FEATURE - UK

Nimmo explains how to make money on AIM

05 Aug 2010 | 17:15
Harry Nimmo

Categories: UK

Topics: | Uk | Aim

nimmo-harry3
  • Tweet

With its mixed track record, investing in AIM has recently been considered the territory of a madman, but can investors find value stocks despite recent poor performance?

If indices are anything to go by the Alternative Investment market (AIM) is a complete dead loss. The FTSE AIM index has fallen by around 32% in the period from launch on 1 January 1996 to July 2010.

Even the ‘blue chip’ FTSE 100 
index has managed a 44% gain over that period, while the RBS Hoare Govett Smaller Companies Index (HG) is up a more impressive 120%.

Ostensibly the HG and the AIM indices cover similar smaller companies: they are both exposed to growth markets; they both include companies in early stages of their development; and both have traditionally been fertile grounds for the new issues market. They feel almost interchangeable to fund managers who are active at the lower ends of the market, with many investing to a large extent in both indices.

In way of an illustration, I currently have around 20% – 13 individual holdings – of our smaller companies fund (OEIC) in AIM stocks. Am I mad? Given AIM’s track record, it looks like the easiest way of picking a pack of losers.

The birth of AIM

AIM was born out of the ashes of the Unlisted Securities Market. It is a place where the listing rules are more flexible; where lower standards of disclosure are required; and where it is cheaper to gain a quote, retain a quote and raise money.

It has also been viewed as a fertile ground for raising risk capital for smaller, riskier, nascent, growth businesses. Many AIM stocks may be little more than an idea, a technology, some drug research, some seismic survey results, some mining acreage in a far off land. Some examples of the oddest companies to raise money are listed below:

l Epitan – the ‘self-browning’ tanning implant with an associated sex-drive enhancing side effect.

l Subsea Resources – the world leader in raising treasure ships from the ocean floor.

l Nautilus Resources – another deep sea company involved in mining gold and copper nodules from the seabed.

l Aqua Bounty – a developer of transgenic fish, most notably the aqua-advantage salmon with added genetic material from the eel like ocean pout to help it grow quicker.

l Best of the Best – a lottery to win ‘supercars’ at airports.

AIM, in spite of its mixed track record, has certainly been a success story when it come to raising equity finance for the pointier end of the smaller development company market. Even after the setbacks of the dotcom bust and the 2007-08 bear market there are still 1,235 companies listed on AIM.

From pawnbrokers to pornography

You can invest in every conceivable sector from pawnbrokers to pornography. There are four individual ways to invest in oil and gas exploration in the Falklands Islands Basin alone. For example, Borders & Southern, Desire Petroleum, Falklands Oil & Gas and Rockhopper (or ‘Rockethopper’ as it is now known in dealing circles).

AIM is, however, subject to fads and is heavily exposed to development companies. Fully 70% of AIM listed companies generate no profits at all.

This has made the market at times very heavily skewed to hot sectors as they come into vogue, eg technology and the internet in 1999-2000, mining and oil and gas in 2005 and 2009 and real estate in 2007.

This has been the market’s downfall when these sectors turned sour. Today the AIM market is still heavily skewed to oil and gas and mining, together making up fully 34% of the whole market. Out of the top 50 largest stocks 26 are oil and gas or mining.

The issue is that investors underestimate the difficulty of turning an idea, a technology, some drilling rights, some drug research into an actual business with proper revenues, profits and even dividends.

Indeed 90% of them fail altogether. The AIM market is littered with the wrecks of companies that once looked so attractive – Clipper Windpower in alternative energy, Tanfield in electric vehicles, and Asia Energy in mining, to name but a few.

The latter underestimated fears of mass population relocation to make way for open cast coal mining at Phulbari in Bangladesh, with tragic consequences when demonstrators stormed their offices.

Nevertheless, I have found AIM to be a great place to generate returns for investors. Our largest two holdings are both AIM stocks – Asos, an online clothing retailer, and Abcam, an online distributor of antibodies.

Both have been in the portfolio for a number of years. Both have been strong performers. Andor Technologies, Craneware, Immunodiagnostic Systems Holdings, Kentz and Mulberry are others that have done well.

The difference is that they are all highly profitable businesses: they might well be mould-breaking ways of doing business, they may harness new technologies, they are all growing rapidly, and crucially they are all highly profitable and leaders in their fields.

They often have founders who are still in charge and are clearly entrepreneurial, but they also have what it takes to transform companies from start ups into profitable businesses. I have found that it is better to wait for the business model to be proven by the generation of profits, even if it means giving up a little of the upside from being involved at the earlier stages.

A casino?

Roel Campos, a senior official of Securities & Exchange Committee (SEC), is quoted as saying the AIM market ‘felt like a casino to me’ and that it ‘was a losing proposition to tout lower standards as a way to promote your markets’.

I would argue that the rate of failure is not that different to the fully listed market. In the last 10 years a depressingly long list of our largest-quoted companies have failed or been laid low, eg Marconi, Colt Telecom, RBS, HBOS, etc. This has occurred despite these companies enjoying the benefits that come from being listed on a fully regulated market.

The reality is that all stock markets are risky and therefore investors should stick to old-fashioned principles, preferring real businesses with revenues, profits and if possible dividends.

 

Harry Nimmo is manager of Standard Life UK Smaller Companies fund and Smaller Companies trust

  • Print
  • Share
  • Comment
  • Nimmo explains how to make money on AIM

More uknews

  • Woodford ditches Tesco as Buffett buys

  • RBS said to dismiss four bankers as FSA probes LIBOR manipulation

  • Barclays' profits fall 3%, bonus pool shrinks by 26%

  • Thomas Cook shares up 8% as bookings remain 'stable'

Email alerts

  • Get similar articles direct to your inbox

Related information

Recommended reading

  • Conjecture: High Yield Bonds

  • Rogers wary of US equities despite roaring markets

  • Would you invest in Facebook now?

  • Bank expands QE by £50bn

  • F&C, Makis Kaketsis

Categories

  • UK

Topics

  • UK

  • AIM

Categories: UK

Topics: | Uk | Aim

  • Comment
  • Email to a friend
  • Print

COMMENTS

defunct Epitan

The "tanning" drug company Epitan changed names to Clinuvel along with management in 2005. Clinuvel redirectioned the company away from cosmetic applications to treat severe orphan conditions with this melanin stimulating drug. Furthermore the drug that produced sexual side effects was never licensed by Epitan, but rather under development by Palatin. these drugs are not the same and affect different receptors.

Posted by: Jacob

22 Aug 2010 | 17:05

Complain about this comment

MOST COMMENTED ARTICLES

  • Spurs boss Redknapp cleared of tax evasion charges

  • FATCA: US Treasury updates proposals to ease burden

  • Woodford ditches Tesco as Buffett buys

  • Buffett: Bonds should come with a health warning

  • Investors 'twice as likely' to choose active funds over trackers - Lipper

AUDIO/VIDEO

  • Conjecture: High Yield Bonds

  • Conjecture: Global Emerging Markets

  • VIDEO: Why Japan is set for a recovery in 2012

  • Conjecture: Global Equities

  • Conjecture: Fixed Income

THE BIG QUESTION

fragment image

Every week, we ask the experts for their views on the latest topics in the industry

  • View all

EVENTS

  • fund5live

  • Senate Spring Investment Conference

  • Absolute Returns Focus 2012

  • Most read
  • Popular topics
  • Related articles
  • F&C, Makis Kaketsis

  • Woodford ditches Tesco as Buffett buys

  • Would you invest in Facebook now?

  • Rogers wary of US equities despite roaring markets

  • Conjecture: High Yield Bonds

  • Close Brothers
  • IMF
  • Inflation
  • Italy
  • Portugal
  • Schroders
  • Spain
  • US
  • Warren Buffett
  • eu
  • Dr Doom: Why the US cannot avoid recession

  • Is the UK a safe haven?

  • How will the US downgrade hit investors?

  • The Big Interview: Richard Phillips

  • Budget 2011: Osborne's speech in full

EDITOR'S CHOICE

1 2 3 4

hale-clive

View from the Bridge: Investment biker

Being a long time motorbiker, I am very conscious of the ever present threat that comes from being unaware of what is in front of you.

Jupiter tops Alpha Manager provider list

Jupiter Unit Trust Managers employs the most FE Alpha Managers with 12 on the newly revealed list for 2012.

lawrence-gosling

Gosling's Grouse: Baying for blood

When a phlebotomist sticks a needle in a vein you pay attention. He or she has you just where they want you.

obama-concerned

FDR, Reagan, Clinton or Obama: When were markets strongest?

Three years into Barack Obama's term as US president, how do equity market returns under this administration compare with those seen under previous leaders?

DIGITAL EDITION

fragment image

Investment Week digital edition

Register now to receive Investment Week in your inbox.

@INVESTMENTWEEK

fragment image

Follow IW on Twitter

Sign up to have all Investment Week's news and analysis tweeted straight to your timeline.
  • Home
  • News
  • Opinion
  • Fund Manager Views
  • Interviews
  • Sector Analysis
  • Features
  • Events
  • Audio/Video
  • Jobs
  • Research Centre
  • Share Centre
logo

© Incisive Media Investments Limited 2012, Published by Incisive Financial Publishing Limited, Haymarket House, 28-29 Haymarket, London SW1Y 4RX, are companies registered in England and Wales with company registration numbers 04252091 & 04252093

  • Site search

sponsored by

Site Credentials:

  • Contact us
  • About Incisive Media
  • Privacy policy
  • Terms & Conditions
  • Accessibility
  • Sitemap

Related websites:

  • IFAonline
  • Professional Adviser
  • Mortgage Solutions
  • Retirement Planner
  • ETFM
  • International Investment
  • Professional Pensions
  • Global Pensions

Jobs:

  • Director/Executive jobs
  • Investment Adviser jobs
  • Investment Analyst jobs
  • Portfolio Manager jobs
  • Private Client Stockbroker jobs
  • Wealth Manager jobs

Accreditations:

  • Digital Publisher of the Year 2010
Tweet